Key facts
| Price (PPV) | 409 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | doxorubicine |
| Class | Antineoplastic agents |
| ATC code | L01DB01 |
| Manufacturer | NOVOPHARMA |
| Presentation | Boîte unitaire |
| Nature | Médicament |
| Hospital price | 272 MAD |
| Data collected on | 9/8/2026 |
Indications
- Carcinomes du sein - Sarcomes des os et des parties molles - Maladie de Hodgkin, lymphomes non hodgkiniens - Tumeurs solides de l'enfant - Cancers du poumon - Leucémies aiguës et chroniques - Cancers de la vessie, de l’ovaire, de l'estomac
Find an open pharmacy
On-call pharmacies near you
About D-Rubicin 50 mg / 50 ml
D-Rubicin 50 mg / 50 ml belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by NOVOPHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of D-Rubicin 50 mg / 50 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about D-Rubicin 50 mg / 50 ml
Answers to common questions from Moroccan patients about this drug.